Walking with Ebola

It's very reassuring that the nation's 1st Ebola patient, Dr. Kent Brantly, walked into Emory's hospital.

The fact that he was ambulatory suggests several things that include:

• He is hemodynamically stable: Dr. Brantly's cardiovascular system is intact enough to allow him to support his own blood pressure and stand upright
• His respiratory system is intact: No requirement for mechanical ventilation is present
• He is able to follow commands: There doesn't appear to be any delerium

Important questions that remain to be answered include will include what role the convalescent serum he received has played in his recovery, how his immune system may differ from others, and what type of supportive care he received prior to therapy.

Also, though this may be the first Ebola patient in the US, it is important to remember that Ebola, the virus, is studied in several laboratories in this country--a point well made by Dr. Tara Smith in this blog post.

A Celebrity, Shigella, and an Airplane

With all the (mostly sensationalized) talk of individuals harboring Ebola traveling to the US from West Africa, I thought of an odd incident involving a sick celebrity traveler I recently heard about.

David Duchovny, the star of The X-Files (a show I predictably loved),  was recently on The Late Late Show and was recounting the story of a trip he had taken to Thailand. During that trip, he contracted a Shigella infection. 

Shigella causes dysentery--a fancy word that means diarrhea that contains pus. Often people with shigellosis will have fevers and chills as well. Shigella is a pathogen that is highly infectious as only a few organisms are required to cause disease. Fortunately, barring antibiotic resistance, Shigella is something that can be treated with antibiotics.

The story that Duchovny related (at about 3:50 in this clip) included him making so many trips to the bathroom that flight attendants suspected him of being a drug mule, prompting a full body inspection upon arrival in the US. Such an inspection of someone with explosive diarrhea is clearly a scenario ripe for contagion.

One of the fascinating aspects of Shigella is that the US military has shown interest in using bacteriophages (viruses that infect and can kill bacteria) as nutritional supplements for troops stationed in areas with a high incidence of Shigella infections. Phages are an elegant, totally targeted, therapy that avoid the issues inherent with broad spectrum antibiotics. There will be more to come on bacteriophages in the future.

As for Duchovny, I'm sure the customs inspectors found out, possibly in an unpleasant manner, that the truth was in there.

miRNAs Have Such Rock Star Status That Real Rock Stars Write About Them

Tonight I went to a concert in which the two bands I went to see were fronted by biologists: Bad Religion (Greg Graffin Ph.D) and Offspring ("Dexter" Holland soon to be Ph.D). 

I go curious as to what they've been publishing in the biomedical literature and found a cool paper published during 2013 in PLoS ONE whose first author is Bryan Holland of Offspring.

I read the paper and it is fascinating. 

The subject of the paper is the phenomenon of miRNA's. These are non-coding (i.e. non-protein making) short pieces of RNA that function to regulate genes. What Holland's paper focuses is on  is miRNA's within the genome of HIV.  The paper argues that 8 miRNA like sequences found in HIV may bind to cellular targets and be responsible for dysregulation of cellular genes. This dysregulation may play a role in HIV's ability to evade host defense, something it does quite readily.

I find the whole topic of RNA fascinating because as the myriad functions of RNA (tRNA, ribozymes, RNAi, miRNA, siRNAs, snRNPs, etc) are detailed it is clear how versatile this molecule is giving a lot of validity that our modern DNA world evolved from an RNA one.

Ebola: Will it Find the US as Inhospitable as Lassa Fever Did?

While the press is speculating on the ability of the Ebola virus to be imported into the US--a fear heightened by the infection of two Americans--I think it is important to remember that Lassa Fever, Ebola's fellow traveler, has trod this ground before. 

Lassa Fever is a hemorrhagic fever endemic in West Africa and spread via rodent urine and through body fluids. It kills about 5000 people yearly in Africa and, although death is rare, it serves as a prototype of what to do with imported Ebola cases. Bottom line: situational awareness coupled with strict infection control.

Recent Lassa importations occurred in New Jersey in 2004, my home of Pennsylvania in 2010, and Minnesota in 2014. In total, approximately 7 cases of Lassa Fever have been identified in travelers in the US. In all cases, no symptomatic secondary transmission were identified. 

While Ebola is a horrific disease and a serious concern in Africa, should it make itself to the US in a traveler incubating the virus, it will find the US as inhospitable as its weaker fellow gang member, Lassa Fever, has repeatedly learned.

HIV & The Will (or its absence) to Live

Although I primarily practice infectious diseases and critical care medicine, I am also trained and board-certified in emergency medicine. To keep somewhat active in the field, I work about one shift per month in an emergency department (ED). I don't often have my infectious disease world intrude into the ED, but yesterday it did. 

I was involved in the care of a AIDS patient with toxoplasmosis who came to the ED for an unrelated reason. However, the infectious disease issue soon supplanted the original reason for the visit. 

Toxoplasmosis occurs in AIDS patients who are severely immunosuppressed. This opportunistic infection, which is treatable, was much more common in earlier eras in which individuals with HIV had no effective treatments. In the modern era, in those who have access to medications, it is quite rare. In my ID fellowship, I think I only saw one case in an individual newly diagnosed with HIV. 

Yesterday's case wasn't like that--this person had willfully stopped taking anti-retrovirals and anti-toxoplasmosis medications. 

I found the entire experience frustrating as I, like many other physicians before me, was futile in  persuading the patient that without treatment death would soon occur. 

As I've learned by myriad interactions with individuals recalcitrant to complying with treatment recommendations, a fundamental choice to live has to be the precondition for anything anyone says to matter.